Health News

• Sarah Axelrath of the Colorado Coalition for the Homeless told the Denver City Council on Monday that targeting drug traffickers does not stop substance use. • Axelrath, an addiction medicine specialist, stated that these law enforcement actions disrupt an already potent and unpredictable drug supply. • This approach suggests that focusing on supply reduction fails to lower overall demand for illegal substances.

• SEMICON India 2026 began in Delhi to showcase the country's goals for semiconductor chip manufacturing. • Italy's Health Force raised €4.2 million to expand its AI health agents across Europe. • Apple added Impersonation Risk Detection to iOS 27 to help users block scams.

• Researchers at the Sylvester Comprehensive Cancer Center found that annual U.S. cancer deaths linked to alcohol consumption more than doubled between 1990 and 2023. • Data published in The Lancet Regional Health — Americas shows these deaths rose from 11,361 in 1990 to 23,126 in 2023. • A separate report from the Association for Accessible Medicines warns that 90% of expensive biologic drugs facing patent expiration by 2034 lack lower-cost alternatives in development.

• The Centers for Disease Control and Prevention declared that the record-setting cyclosporiasis outbreak linked to iceberg lettuce has ended. • Health officials confirmed that all contaminated iceberg lettuce sourced from central Mexico and recalled by Taylor Farms de Mexico is now off the market. • Consumers no longer face a risk of getting sick from this specific batch of contaminated produce.

• The FDA approved a first-of-its-kind oral treatment from Roivant and Priovant Therapeutics for a rare disease affecting skin and muscles. • Following the announcement on Thursday, Roivant shares saw a 2% increase, closing at $37.58 in afternoon trading. • Simultaneously, the FDA and CDC expanded a cyclosporiasis outbreak investigation to 20 states after detecting new cases linked to iceberg lettuce from central Mexico.

• The Australian Medical Association (AMA) has issued a new position statement urging specialist medical colleges to increase the transparency of their fees. • This move aims to provide patients with clearer information regarding the costs associated with specialist medical services. • The initiative matters as it addresses growing concerns over healthcare affordability and the lack of pricing clarity for patients navigating the system.

• New research from France suggests that stopping cholesterol-lowering statins at age 75 may be harmless for patients with no history of cardiovascular disease. • A separate Duke University study confirms that the real-world safety and effectiveness of the Alzheimer’s drug lecanemab (Leqembi) align with its original clinical trial data. • Despite risks of brain swelling and bleeding (ARIA), approximately 80% of early-stage Alzheimer's patients remained on lecanemab treatment for at least one year.

• A U.S. study highlights the high economic burden of measles outbreaks, estimating that a single event can cost millions of dollars in healthcare and public-health response. • Global health efforts are shifting toward infectious disease preparedness, including the U.S. FDA's approval of Moderna’s first mRNA influenza vaccine. • In India, research suggests that implementing a hexavalent vaccine could enhance the national immunisation programme, while ICAR has developed an indigenous vaccine for African swine fever.

The alerts come a day after it was officially declared that there are now 11 regions in the country in droughtHealth alerts are set to come into force across England this morning as parts of the UK brace for fifth climate crisis-driven heatwave this summer.Amber heat health alerts have been issued for all regions in England, except the north-east, which mean significant impacts are likely across health and social care services due to the high temperatures, according to the UK’s Health Security Agency (UKHSA). The alerts stretch from 9am on Tuesday until 9am on Friday. Continue reading...

• On August 9, 2026, Iranian President Masoud Pezeshkian met with Mojtaba Khamenei amid reports regarding the Supreme Leader's health. • Reports indicate that the Supreme Leader's medical condition has become "extremely critical," sparking concerns over the country's leadership. • This meeting is significant as it suggests potential preparations for a transition of power within Iran's high-level political structure.

• On Thursday, August 6, 2026, the FDA granted accelerated approval to vusolimogene oderparepvec (Tudriqev), also known as RP1, for use in combination with nivolumab (Opdivo). • This genetically modified oncolytic viral therapy is specifically indicated for adults with unresectable advanced cutaneous melanoma who have seen disease progression after anti-PD-1-based therapy. • Karim Mikhail, acting director of the FDA's Center for Biologics Evaluation and Research, stated that the approval provides more patients with a "fighting chance" against advanced cancer.

• Manipal Health Enterprises' $960.4 million IPO was oversubscribed, driven largely by institutional investors, while Glenmark Pharma reported a 53.6% increase in quarterly profits. • An FDA advisory panel voted on Thursday to support trial results for Replimune's skin cancer drug, RP1, following two previous FDA rejections. • The FDA had previously denied approval in April due to a lack of a control group and insufficient evidence of the drug's effectiveness.

• Sophia, a member of the group KATSEYE, announced a hiatus on August 8, 2026, to prioritize her mental health. • The announcement comes at a critical time as the group prepares for an upcoming album release. • This move highlights the increasing focus on mental wellness within the high-pressure global entertainment industry.

• Manipal Health Enterprises' IPO saw strong oversubscription driven by institutional investors, while Glenmark Pharmaceuticals reported a 53.6% increase in quarterly profit. • An FDA advisory panel voted on Thursday to support trial results for Replimune's skin cancer drug, RP1, following a previous rejection in April due to a lack of a control group. • Merck and Wellcome have partnered with a global health group to develop an Ebola vaccine intended for upcoming clinical trials.

• Researcher Eric Verdin is studying experimental drugs, specifically GLP-1 medications, to determine if they can extend human life and mimic the benefits of calorie restriction. • While calorie restriction is known to improve lifespan and reduce age-related diseases, many individuals struggle to maintain the strict diets required to achieve these results. • GLP-1 medications, which are part of a broad class of compounds known as peptides, are being explored as a pharmacological alternative to dietary restriction.

• Betting platforms Kalshi and Polymarket now allow users to wager on whether the FDA will approve treatments for lung, breast, pancreas, and blood cancers this year. • Kalshi intends to expand its offerings by allowing users to bet on the specific outcomes of clinical drug trials. • Simultaneously, the FDA has reiterated concerns regarding Replimune's lack of adequate data as the biotech company attempts for a third time to gain clearance for a controversial skin cancer drug.

• The Department of Veterans Affairs is launching a randomized clinical trial to determine if GLP-1 drugs can reduce alcohol abuse among U.S. military veterans. • The study will specifically measure whether semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, can decrease drinking and improve overall quality of life. • This initiative targets a significant public health need, as an estimated 400,000 U.S. veterans are currently diagnosed with alcohol use disorder.

• New research indicates that individuals using cannabis for self-medication face increased risks of paranoia and typically consume higher levels of THC. • The study highlights that childhood trauma further amplifies these psychological risks, creating a more dangerous interaction for vulnerable users. • These findings are critical as they challenge the perceived safety of self-treating mental health issues with cannabis without professional guidance.

• An FDA advisory panel voted on Thursday to support trial results for Replimune's drug, RP1, which targets a specific type of skin cancer. • The FDA had previously declined to approve RP1 twice, most recently in April, due to a lack of a control group and insufficient evidence of effectiveness. • This panel's endorsement provides critical momentum for the drug's approval process after the agency demanded more comprehensive data.

• The FDA’s Pharmacy Compounding Advisory Committee has approved the peptides epitalon and semax for compounding. • Medical experts warn that this decision may mislead the public into believing the FDA has thoroughly evaluated the safety and efficacy of these compounds. • Critics argue the move is significant because it could potentially undermine the integrity and future of the formal FDA drug approval process.

• Actor Salman Khan shared a cryptic social media post on July 25, 2026, showcasing his toned physique from the gym. • The post comes amid ongoing public concerns regarding the actor's health, prompting a wave of reactions from his fans. • This update is part of a broader real-time coverage of the $2.83 trillion global entertainment industry, including celebrity buzz and movie trends.

• Researchers at the Johns Hopkins University Bloomberg School of Public Health published a new study on July 20, 2026, regarding formulary-related insurance denials for single-source branded drugs in the U.S. • The report highlights how drug utilization management tools, such as prior authorization, step therapy, and formulary exclusions, are used to reduce overall drug spending. • This is significant because while these measures lower costs for insurers, they may create critical barriers to patient access for essential branded medications.

• Global health news was dominated by climate-linked crises, conflict, and infectious diseases, including a European heatwave linked to over 10,000 deaths. • Significant health threats emerged globally, including the first detection of H5 bird flu in New Zealand, an ongoing Ebola outbreak in Congo, and cyclosporiasis in the U.S. • France is advancing toward the approval of assisted-dying legislation following years of national debate.

• Global health news this week was dominated by climate-linked crises, conflict, and infectious disease outbreaks. • An early European heatwave caused over 10,000 estimated deaths, with a significant spike in mortality reported in the Paris region. • Multiple health threats emerged globally, including New Zealand's first detection of H5 bird flu, an ongoing Ebola outbreak in Congo, and cyclosporiasis cases in the U.S.

• PolitiFact, a project of the Poynter Institute, has launched "Well Informed," a new service designed to provide reliable health information to consumers and news organizations. • The initiative utilizes research-backed stories and social videos to help the public distinguish credible medical evidence from health-related misinformation. • This launch addresses the growing need for verified health data to combat the spread of misleading personal health claims across digital platforms.

• Educationist and activist Sonam Wangchuk has been hospitalized and is currently reported as "weak but stable" by Safdarjung Hospital. • The hospitalization follows a Delhi High Court order requiring daily health checks for Wangchuk due to his deteriorating physical condition. • Wangchuk has transitioned from a grassroots innovator to a national figure leading political and environmental movements in Ladakh, as well as Gen Z education reforms.

• The Pharmaceutical Journal reported on several key healthcare developments, including progress toward a single national formulary and the potential introduction of a pharmacy performers list. • The publication highlighted a "stark lack of government response" regarding the valproate redress scheme, signaling ongoing frustration over compensation for affected individuals. • Efforts are underway to establish closer regulatory ties between the UK, India, and the United States to streamline pharmaceutical oversight.